Question: are keytruda and opdivo the same drug?
Answer: Opdivo and Keytruda approved in new lung cancer uses. The FDA has approved Merck's Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), after green-lighting Bristol-Myers Squibb's (BMS) rival blockbuster Opdivo (nivolumab) for small cell lung cancer (SCLC).